期刊
SWISS MEDICAL WEEKLY
卷 145, 期 -, 页码 -出版社
E M H SWISS MEDICAL PUBLISHERS LTD
DOI: 10.4414/smw.2015.14202
关键词
pulmonary hypertension; pathogenesis; vasoconstriction; microthrombosis; vascular remodelling; bone morphogenetic protein receptor type II (BMPR2)
资金
- Swiss National Science Foundation (SNF Grant) [31003A_144212]
- Swiss National Science Foundation (SNF) [31003A_144212] Funding Source: Swiss National Science Foundation (SNF)
Elevation of the mean pulmonary arterial pressure to >= 25 mm Hg within the low-pressure system of the pulmonary circulation is defined as pulmonary hypertension. Pulmonary hypertension may be the consequence of various clinical and pathophysiological entities. Many of these conditions, however, result in a final common pathway of pathogenesis. This pathway is characterised by the triad of excessive vasoconstriction, microthrombosis and remodelling of pulmonary arteries. Remodelling is arguably the most important factor: its complex pathogenesis is not completely understood and no specific treatment directly targets vascular remodelling. This article aims to review the current understanding of the pathogenesis of pulmonary hypertension and to give insights in future developments in this evolving field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据